Cartherics to present at the ISSCR 2025 Boston International Symposium
By Christine Filippis / December 8, 2025
Cartherics’ Deputy Chair, Prof. Alan Trounson AO will be presenting at ISSCR 2025 on Friday 12th December, 2025 at 3.25pm...
Read More
Launch of Evinco Therapeutics: A pioneering biotech company advancing immune therapies for Alzheimer’s disease
By Christine Filippis / December 4, 2025
Evinco Therapeutics is an Australian start-up on a mission to transform the treatment of Alzheimer’s disease and other neuroinflammatory conditions...
Read More
Cartherics appoints Dr Ian Nisbet as Chief Executive Officer
By Christine Filippis / November 28, 2025
Dr Ian Nisbet appointed as Chief Executive Officer Prof Alan Trounson AO will move into the role of Deputy...
Read More
Cartherics to present at ANZSEV 2025
By Christine Filippis / November 17, 2025
Cartherics is pleased to announce that it will be presenting at the 8th Australian and New Zealand Society for Extracellular...
Read More
Cartherics achieves clean room certification to support clinical-grade cell therapy manufacturing
By Christine Filippis / October 27, 2025
Cartherics is proud to announce the successful certification of our new clean room facility, marking a significant milestone in our...
Read More
Cartherics hosts Frocktober afternoon tea for ovarian cancer awareness
By Christine Filippis / October 15, 2025
Today, Cartherics proudly hosted a Frocktober Afternoon Tea in support of ovarian cancer awareness and research. Frocktober is a meaningful...
Read More
The Next Generation of Cell Therapy with Cartherics’ COO Dr. Ian Nisbet
By Christine Filippis / October 1, 2025
Cartherics’ COO, Dr Ian Nisbet recently joined Xtalks’ Life Science Podcast to discuss Cartherics’ vision for next generation cell therapies. He discussed how Cartherics’ platform is building an effectively unlimited supply...
Read More
Cartherics Wins ‘Most Promising iPSC Therapy Pipeline in APAC’ at Asia Pacific Cell & Gene Therapy Excellence Awards
By Christine Filippis / September 11, 2025
Melbourne, Australia, 11 September 2025 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies...
Read More
Cartherics CEO Prof. Alan Trounson featured on 10News+
By Christine Filippis / September 2, 2025
Cartherics is proud to share that our CEO, Professor Alan Trounson, was recently interviewed on 10 News+ by journalists Amelia...
Read More
Cartherics Granted Chinese Patent for Enhancing Immune Cell Function
By Christine Filippis / August 27, 2025
Melbourne, Australia, 27 August 2025 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies...
Read More
Cartherics Unveils State-Of-The-Art Cleanroom Facility for Cell Therapy Manufacturing
By Christine Filippis / August 6, 2025
Melbourne, Australia, 6 August 2025 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune stem cell...
Read More
Congratulations Dr Mathew Tiedemann!
By Christine Filippis / July 16, 2025
Cartherics is pleased to announce that Mathew Tiedemann has officially completed his PhD, a major milestone in an already impressive...
Read More
The critical importance of navigating the complexity of healthcare markets
By Christine Filippis / July 11, 2025
In the competitive biotech landscape, groundbreaking science alone isn't enough. As highlighted in a recent article by Dynamic Business, Cartherics'...
Read More
Cartherics COO Dr Ian Nisbet on the promise of CAR-NK cells for cancer and endometriosis at BIO 2025
By Christine Filippis / June 18, 2025
In the lead-up to BIO, Cartherics’ COO, Dr Ian Nisbet was interviewed by BioSpectrum Asia to discuss the company’s innovative...
Read More
Using Gene-edited Killer Cells to Target Cancer, Endometriosis and Beyond
By Christine Filippis / June 12, 2025
Cartherics is delighted to be featured in the June 2025 issue of Pharma Technology Focus, drawing attention to our innovative...
Read More
